Artwork

Innhold levert av Middle East Eye. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Middle East Eye eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Narco-Diplomacy: How Bashar al-Assad used Captagon to survive the Syrian War | Lina Khatib

35:42
 
Del
 

Manage episode 371908640 series 3438634
Innhold levert av Middle East Eye. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Middle East Eye eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

What happens when a dictator uses drug trafficking as a tool of diplomacy?

The psychoactive drug known as Captagon has exploded across the Middle East and Europe, leading many countries to clasify it as an ‘epidemic’. The highly-addictive pill used to be made in Turkey and Latin America, but that slowly changed after the Syrian Civil War.

Today, 80% of the global supplies come from Syria, and many have accused Bashar al-Assad of using the drug to generate billions in revenue for the government, bypassing sanctions, and to put pressure on his neighbours to resume diplomatic ties.

That gambit seems to have paid off in May when, after more than 10 years, Syria was welcomed back into the Arab League.

In this week’s episode of The Big Picture, we sit down with Dr Lina Khatib, head of the Middle East Institute at SOAS University. Dr Khatib says despite years of sanctions and political pressure, Assad has emerged feeling victorious.

We'd love to hear your thoughts on this episode, and any guests you'd like us to have on our show. Reach us by email at mh@middleeasteye.org or find us on instagram @BigPictureMee.
You can also watch all our episodes on our YouTube channel here: https://www.youtube.com/playlist?list=PLMyaP73Ho1ySj3cO0OSOHZAOgD1WTDixG

  continue reading

56 episoder

Artwork
iconDel
 
Manage episode 371908640 series 3438634
Innhold levert av Middle East Eye. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Middle East Eye eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

What happens when a dictator uses drug trafficking as a tool of diplomacy?

The psychoactive drug known as Captagon has exploded across the Middle East and Europe, leading many countries to clasify it as an ‘epidemic’. The highly-addictive pill used to be made in Turkey and Latin America, but that slowly changed after the Syrian Civil War.

Today, 80% of the global supplies come from Syria, and many have accused Bashar al-Assad of using the drug to generate billions in revenue for the government, bypassing sanctions, and to put pressure on his neighbours to resume diplomatic ties.

That gambit seems to have paid off in May when, after more than 10 years, Syria was welcomed back into the Arab League.

In this week’s episode of The Big Picture, we sit down with Dr Lina Khatib, head of the Middle East Institute at SOAS University. Dr Khatib says despite years of sanctions and political pressure, Assad has emerged feeling victorious.

We'd love to hear your thoughts on this episode, and any guests you'd like us to have on our show. Reach us by email at mh@middleeasteye.org or find us on instagram @BigPictureMee.
You can also watch all our episodes on our YouTube channel here: https://www.youtube.com/playlist?list=PLMyaP73Ho1ySj3cO0OSOHZAOgD1WTDixG

  continue reading

56 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett